📋 NEURONETICS, INC. (STIM) - Clinical Trial Update
Filing Date: 2026-04-06
Accepted: 2026-04-06 16:40:19
Event Type: Clinical Trial Update
Event Details:
NEURONETICS, INC. (STIM) Announces Clinical Trial Update
NEURONETICS, INC. (STIM) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: leader
Diseases/Conditions: neuroscience
Collaboration: Company
Updated Timeline: fourth quarter 2025
🔬 Clinical Development Pipeline (NEURONETICS, INC.):
Product
Type
Development Stage
Therapeutic Area
Source
Neurostar Transcranial Magnetic Stimulation Therapy System
DEVICE
Approved
Hoarding
ClinicalTrials.gov
rTMS Treatment
DEVICE
Approved
Generalized Anxiety Disorder
ClinicalTrials.gov
Repetitive Transcranial Magnetic Stimulation
DEVICE
Phase PHASE3
Major Depressive Disorder
ClinicalTrials.gov
Oasis
DEVICE
Phase PHASE4
Tinnitus
ClinicalTrials.gov
Sham Transcranial Magnetic Stimulation
DEVICE
Approved
Pain
ClinicalTrials.gov
Active Transcranial Magnetic Stimulation
DEVICE
Approved
Pain
ClinicalTrials.gov
repetitive Transcranial Magnetic Stimulation (rTMS)
DEVICE
Approved
Depression
ClinicalTrials.gov
Magnetic Resonance Spectroscopy and Imaging
DEVICE
Preclinical
Major Depressive Disorder, Recurrent, Mild
ClinicalTrials.gov
Transcranial Magnetic Stimulation (TMS)
DEVICE
Approved
Posttraumatic Stress Disorder
ClinicalTrials.gov
Pupillary Assessment
OTHER
Preclinical
Brain Concussion
ClinicalTrials.gov
Transcranial Magnetic Stimulator
DEVICE
Preclinical
Major Depressive Disorder
ClinicalTrials.gov
NPi-200 and NPi-300 pupillometers
DEVICE
Preclinical
Critical Illness
ClinicalTrials.gov
Sham Comparator
DEVICE
Approved
Schizophrenia
ClinicalTrials.gov
NeuroStar XPLOR®
DEVICE
Approved
Major Depressive Disorder
ClinicalTrials.gov
NeuroStar TMS Therapy® System
DEVICE
Approved
Major Depressive Disorder
ClinicalTrials.gov
Botulinum toxin injections
PROCEDURE
Approved
Primary Cervical Dystonia
ClinicalTrials.gov
Craniocervical Dystonia Questionnaire (CDQ-24)
OTHER
Approved
Primary Cervical Dystonia
ClinicalTrials.gov
Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)
OTHER
Approved
Primary Cervical Dystonia
ClinicalTrials.gov
Sham NeuroStar TMS therapy
DEVICE
Approved
Primary Cervical Dystonia
ClinicalTrials.gov
NeuroStar TMS therapy
DEVICE
Approved
Primary Cervical Dystonia
ClinicalTrials.gov
Cerebellar-brain Inhibition (CBI)
OTHER
Approved
Primary Cervical Dystonia
ClinicalTrials.gov
Tremor electrophysiology
OTHER
Approved
Primary Orthostatic Tremor
ClinicalTrials.gov
10m walk test
OTHER
Approved
Primary Orthostatic Tremor
ClinicalTrials.gov
Timed "Up & Go" Test (TUG) test
OTHER
Approved
Primary Orthostatic Tremor
ClinicalTrials.gov
Fullerton Advanced Balance (FAB) Scale
OTHER
Approved
Primary Orthostatic Tremor
ClinicalTrials.gov
Sham Magstim RapidStim2
DEVICE
Approved
Primary Orthostatic Tremor
ClinicalTrials.gov
Magstim RapidStim2
DEVICE
Approved
Primary Orthostatic Tremor
ClinicalTrials.gov
NeuroStar TMS
DEVICE
Approved
Major Depressive Disorder
ClinicalTrials.gov
Transcranial Magnetic Stimulation
DEVICE
Preclinical
MDD
ClinicalTrials.gov
NeuroStar Transcranial Magnetic Stimulation (TMS)
DEVICE
Approved
Depression, Postpartum
ClinicalTrials.gov
Patients treated with Esketamine
DRUG
Preclinical
Depression
ClinicalTrials.gov
Patients treated with NeuroStar TMS
DEVICE
Preclinical
Depression
ClinicalTrials.gov
rTMS
DEVICE
Approved
Schizophrenia
ClinicalTrials.gov
Sham NeuroStar® Transcranial Magnetic Stimulation (TMS)
DEVICE
Approved
Major Depressive Disorder
ClinicalTrials.gov
Active NeuroStar® Transcranial Magnetic Stimulation (TMS)
📋 NEURONETICS, INC. (STIM) - Clinical Trial Update
Filing Date: 2026-04-06
Accepted: 2026-04-06 16:40:19
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (NEURONETICS, INC.):
💼 Business Developments:
Structured Data: